551 related articles for article (PubMed ID: 31182684)
1. Pathogenesis of Atopic Dermatitis: Current Paradigm.
Furue M; Ulzii D; Vu YH; Tsuji G; Kido-Nakahara M; Nakahara T
Iran J Immunol; 2019 Jun; 16(2):97-107. PubMed ID: 31182684
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-31 and interleukin-31 receptor: New therapeutic targets for atopic dermatitis.
Nakashima C; Otsuka A; Kabashima K
Exp Dermatol; 2018 Apr; 27(4):327-331. PubMed ID: 29524262
[TBL] [Abstract][Full Text] [Related]
3. Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis.
van den Bogaard EH; Bergboer JG; Vonk-Bergers M; van Vlijmen-Willems IM; Hato SV; van der Valk PG; Schröder JM; Joosten I; Zeeuwen PL; Schalkwijk J
J Clin Invest; 2013 Feb; 123(2):917-27. PubMed ID: 23348739
[TBL] [Abstract][Full Text] [Related]
4. Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis.
Suárez-Fariñas M; Dhingra N; Gittler J; Shemer A; Cardinale I; de Guzman Strong C; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol; 2013 Aug; 132(2):361-70. PubMed ID: 23777851
[TBL] [Abstract][Full Text] [Related]
5. Selective ablation of Ctip2/Bcl11b in epidermal keratinocytes triggers atopic dermatitis-like skin inflammatory responses in adult mice.
Wang Z; Zhang LJ; Guha G; Li S; Kyrylkova K; Kioussi C; Leid M; Ganguli-Indra G; Indra AK
PLoS One; 2012; 7(12):e51262. PubMed ID: 23284675
[TBL] [Abstract][Full Text] [Related]
6. IL-1β induces thymic stromal lymphopoietin and an atopic dermatitis-like phenotype in reconstructed healthy human epidermis.
Bernard M; Carrasco C; Laoubi L; Guiraud B; Rozières A; Goujon C; Duplan H; Bessou-Touya S; Nicolas JF; Vocanson M; Galliano MF
J Pathol; 2017 Jun; 242(2):234-245. PubMed ID: 28191908
[TBL] [Abstract][Full Text] [Related]
7. Persistent kallikrein 5 activation induces atopic dermatitis-like skin architecture independent of PAR2 activity.
Zhu Y; Underwood J; Macmillan D; Shariff L; O'Shaughnessy R; Harper JI; Pickard C; Friedmann PS; Healy E; Di WL
J Allergy Clin Immunol; 2017 Nov; 140(5):1310-1322.e5. PubMed ID: 28238749
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the mechanism for the development of allergic skin inflammation and the application for its treatment:keratinocytes in atopic dermatitis - their pathogenic involvement.
Komine M
J Pharmacol Sci; 2009 Jul; 110(3):260-4. PubMed ID: 19609063
[TBL] [Abstract][Full Text] [Related]
9. Basics and recent advances in the pathophysiology of atopic dermatitis.
Nakahara T; Kido-Nakahara M; Tsuji G; Furue M
J Dermatol; 2021 Feb; 48(2):130-139. PubMed ID: 33118662
[TBL] [Abstract][Full Text] [Related]
10. OX40 ligand and OX40 are increased in atopic dermatitis lesions but do not correlate with clinical severity.
Ilves T; Harvima IT
J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):e197-205. PubMed ID: 22646697
[TBL] [Abstract][Full Text] [Related]
11. The IL-13-OVOL1-FLG axis in atopic dermatitis.
Furue K; Ito T; Tsuji G; Ulzii D; Vu YH; Kido-Nakahara M; Nakahara T; Furue M
Immunology; 2019 Dec; 158(4):281-286. PubMed ID: 31509236
[TBL] [Abstract][Full Text] [Related]
12. Expression of IL-22 in the Skin Causes Th2-Biased Immunity, Epidermal Barrier Dysfunction, and Pruritus via Stimulating Epithelial Th2 Cytokines and the GRP Pathway.
Lou H; Lu J; Choi EB; Oh MH; Jeong M; Barmettler S; Zhu Z; Zheng T
J Immunol; 2017 Apr; 198(7):2543-2555. PubMed ID: 28228560
[TBL] [Abstract][Full Text] [Related]
13. Th2 Modulation of Transient Receptor Potential Channels: An Unmet Therapeutic Intervention for Atopic Dermatitis.
Meng J; Li Y; Fischer MJM; Steinhoff M; Chen W; Wang J
Front Immunol; 2021; 12():696784. PubMed ID: 34276687
[TBL] [Abstract][Full Text] [Related]
14. Drug evaluation review: dupilumab in atopic dermatitis.
Hamilton JD; Ungar B; Guttman-Yassky E
Immunotherapy; 2015; 7(10):1043-58. PubMed ID: 26598956
[TBL] [Abstract][Full Text] [Related]
15. Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis.
Guttman-Yassky E; Bissonnette R; Ungar B; Suárez-Fariñas M; Ardeleanu M; Esaki H; Suprun M; Estrada Y; Xu H; Peng X; Silverberg JI; Menter A; Krueger JG; Zhang R; Chaudhry U; Swanson B; Graham NMH; Pirozzi G; Yancopoulos GD; D Hamilton JD
J Allergy Clin Immunol; 2019 Jan; 143(1):155-172. PubMed ID: 30194992
[TBL] [Abstract][Full Text] [Related]
16. Counterregulation between thymic stromal lymphopoietin- and IL-23-driven immune axes shapes skin inflammation in mice with epidermal barrier defects.
Li J; Leyva-Castillo JM; Hener P; Eisenmann A; Zaafouri S; Jonca N; Serre G; Birling MC; Li M
J Allergy Clin Immunol; 2016 Jul; 138(1):150-161.e13. PubMed ID: 26993035
[TBL] [Abstract][Full Text] [Related]
17. GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis.
Guttman-Yassky E; Pavel AB; Zhou L; Estrada YD; Zhang N; Xu H; Peng X; Wen HC; Govas P; Gudi G; Ca V; Fang H; Salhi Y; Back J; Reddy V; Bissonnette R; Maari C; Grossman F; Wolff G
J Allergy Clin Immunol; 2019 Aug; 144(2):482-493.e7. PubMed ID: 30738171
[TBL] [Abstract][Full Text] [Related]
18. Exploration of biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab: A study protocol.
Nakahara T; Izuhara K; Onozuka D; Nunomura S; Tamagawa-Mineoka R; Masuda K; Ichiyama S; Saeki H; Kabata Y; Abe R; Ohtsuki M; Kamiya K; Okano T; Miyagaki T; Ishiuji Y; Asahina A; Kawasaki H; Tanese K; Mitsui H; Kawamura T; Takeichi T; Akiyama M; Nishida E; Morita A; Tonomura K; Nakagawa Y; Sugawara K; Tateishi C; Kataoka Y; Fujimoto R; Kaneko S; Morita E; Tanaka A; Hide M; Aoki N; Sano S; Matsuda-Hirose H; Hatano Y; Takenaka M; Murota H; Katoh N; Furue M
Medicine (Baltimore); 2020 Sep; 99(38):e22043. PubMed ID: 32957324
[TBL] [Abstract][Full Text] [Related]
19. Influence of Th2 Cytokines on the Cornified Envelope, Tight Junction Proteins, and ß-Defensins in Filaggrin-Deficient Skin Equivalents.
Hönzke S; Wallmeyer L; Ostrowski A; Radbruch M; Mundhenk L; Schäfer-Korting M; Hedtrich S
J Invest Dermatol; 2016 Mar; 136(3):631-639. PubMed ID: 27015451
[TBL] [Abstract][Full Text] [Related]
20. Atopic dermatitis: immune deviation, barrier dysfunction, IgE autoreactivity and new therapies.
Furue M; Chiba T; Tsuji G; Ulzii D; Kido-Nakahara M; Nakahara T; Kadono T
Allergol Int; 2017 Jul; 66(3):398-403. PubMed ID: 28057434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
